Dolby Laboratories (DLB) Current Deferred Revenue (2009 - 2026)

Dolby Laboratories has reported Current Deferred Revenue for 18 years, with the latest figure at $38.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue fell 1.96% year-over-year to $38.8 million; the trailing twelve-month figure through Mar 2026 stood at $38.8 million (down 1.96% YoY), and the FY2025 full-year result was $31.4 million, down 0.83% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $38.8 million, up from $37.1 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $39.6 million in Q1 2025, with the low at $18.6 million in Q3 2022.
• Historically, Current Deferred Revenue has averaged $31.2 million across 5 years, with a median of $32.6 million in 2024.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue jumped 72.45% — and 2024, when it fell 10.76%.
• Dolby Laboratories' Current Deferred Revenue stood at $22.4 million in 2022, then soared by 49.42% to $33.4 million in 2023, then gained by 11.1% to $37.1 million in 2024, then slipped by 0.05% to $37.1 million in 2025, then gained by 4.7% to $38.8 million in 2026.
• The last three Current Deferred Revenue figures came in at $38.8 million (Q1 2026), $37.1 million (Q4 2025), and $31.4 million (Q3 2025), per Business Quant data.